BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 17505503)

  • 1. Consumer exposure scenarios: development, challenges and possible solutions.
    Van Engelen JG; Heinemeyer G; Rodriguez C
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S26-33. PubMed ID: 17505503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk management measures for chemicals in consumer products: documentation, assessment, and communication across the supply chain.
    Bruinen de Bruin Y; Hakkinen PB; Lahaniatis M; Papameletiou D; Del Pozo C; Reina V; Van Engelen J; Heinemeyer G; Viso AC; Rodriguez C; Jantunen M
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S55-66. PubMed ID: 17609687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental exposure scenarios: development, challenges and possible solutions.
    Ahrens A; Traas TP
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S7-15. PubMed ID: 18000528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exposure scenarios for workers.
    Marquart H; Northage C; Money C
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S16-25. PubMed ID: 17851448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REACH: next step to a sound chemicals management.
    Van der Wielen A
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S2-6. PubMed ID: 17637708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Issues in consumer exposure modeling: towards harmonization on a global scale.
    Kephalopoulos S; Bruinen de Bruin Y; Arvanitis A; Hakkinen P; Jantunen M
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S90-100. PubMed ID: 17668010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic exposure scenarios: their development, application, and interpretation under REACH.
    Money C; Margary A; Noij D; Hommes K
    Ann Occup Hyg; 2011 Jun; 55(5):451-64. PubMed ID: 21551289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From dermal exposure to internal dose.
    Van de Sandt JJ; Dellarco M; Van Hemmen JJ
    J Expo Sci Environ Epidemiol; 2007 Dec; 17 Suppl 1():S38-47. PubMed ID: 17440485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safe usage of chemicals in European Union countries].
    Graczyk A; Czerczak S; Barański B
    Med Pr; 2010; 61(3):333-40. PubMed ID: 20677433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Background of REACH in EU regulations on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jun; 27(6):443-61. PubMed ID: 18784197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond REACH: roadblocks and shortcuts en route to integrated risk assessment and management of chemicals.
    Assmuth T; Hildén M; Craye M
    Sci Total Environ; 2010 Aug; 408(18):3954-63. PubMed ID: 20347473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessments of direct human exposure: the approach of EU risk assessments compared to scenario-based risk assessment.
    Wormuth M; Demou E; Scheringer M; Hungerbühler K
    Risk Anal; 2007 Aug; 27(4):979-90. PubMed ID: 17958505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PBT assessment using the revised annex XIII of REACH: a comparison with other regulatory frameworks.
    Moermond CT; Janssen MP; de Knecht JA; Montforts MH; Peijnenburg WJ; Zweers PG; Sijm DT
    Integr Environ Assess Manag; 2012 Apr; 8(2):359-71. PubMed ID: 22006646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narrow-and-sharp or broad-and-blunt--regulations of hazardous chemicals in consumer products in the European Union.
    Molander L; Rudén C
    Regul Toxicol Pharmacol; 2012 Apr; 62(3):523-31. PubMed ID: 22107914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toward a nontoxic poison: current trends in (European Union) biocides regulation.
    Kähkönen E; Nordström K
    Integr Environ Assess Manag; 2008 Oct; 4(4):471-7. PubMed ID: 18605757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
    Boogaard PJ; Hays SM; Aylward LL
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concept of REACH and impact on evaluation of chemicals.
    Foth H; Hayes A
    Hum Exp Toxicol; 2008 Jan; 27(1):5-21. PubMed ID: 18480145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conscious worst case definition for risk assessment, part I: a knowledge mapping approach for defining most critical risk factors in integrative risk management of chemicals and nanomaterials.
    Sørensen PB; Thomsen M; Assmuth T; Grieger KD; Baun A
    Sci Total Environ; 2010 Aug; 408(18):3852-9. PubMed ID: 19945144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.